デフォルト表紙
市場調査レポート
商品コード
1753445

大腸手術の世界市場

Colorectal Procedure


出版日
ページ情報
英文 385 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
大腸手術の世界市場
出版日: 2025年06月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 385 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

大腸手術の世界市場は2030年までに347億米ドルに到達

2024年に175億米ドルと推定される大腸手術の世界市場は、2024年から2030年にかけてCAGR 12.1%で成長し、2030年には347億米ドルに達すると予測されます。本レポートで分析したセグメントの一つである右半球切除術は、CAGR 9.8%を記録し、分析期間終了時には106億米ドルに達すると予測されます。左半切除手術セグメントの成長率は、分析期間中CAGR 14.1%と推定されます。

米国市場は48億米ドルと推定、中国はCAGR15.9%で成長予測

米国の大腸手術市場は2024年に48億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに71億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは15.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ9.0%と10.6%と予測されています。欧州では、ドイツがCAGR約9.5%で成長すると予測されています。

世界の大腸手術市場- 主要動向と促進要因まとめ

大腸肛門手術が世界的に臨床的・戦略的重要性を増しているのはなぜか?

大腸がん、炎症性腸疾患(IBD)、憩室炎、良性ポリープを含む大腸疾患の有病率の上昇により、大腸肛門処置は世界のヘルスケアシステムの中心的存在になりつつあります。これらの処置は、大腸内視鏡検査、ポリープ切除、大腸切除、吻合、低侵襲の腹腔鏡手術やロボット支援手術など、幅広い診断、治療、外科的介入を包含しています。世界人口の高齢化は、座りがちなライフスタイル、食生活の変化、消化器疾患の増加などと相まって、タイムリーな大腸肛門の介入に対する需要を押し上げています。

さらに、特に大腸がんの早期診断と予防的スクリーニングへのシフトは、手技件数の大幅な増加につながっています。多くの国で国家スクリーニングプログラムが実施され、診断的大腸内視鏡検査や関連治療手技へのアクセスが拡大しています。画像診断、生検技術、手術器具の進歩により、手技の精度と患者の転帰が向上し、大腸手技は消化器ケアと腫瘍学サービスの中で優先順位の高いカテゴリーに位置づけられています。

技術の進歩は大腸手術の治療成績をどのように変えているか?

大腸手術市場は、特に低侵襲手術(MIS)の領域で、技術的な変革を目の当たりにしています。腹腔鏡機器、ロボット支援システム、高精細内視鏡の革新は、外科的介入の侵襲性を低減し、入院期間の短縮、術後の痛みの軽減、回復時間の短縮をもたらしました。特にロボットプラットフォームは、複雑な結腸直腸切除術や骨盤手術において、器用さ、可視化、精度の向上をもたらし、その地位を確立しつつあります。

同時に、大腸ステント留置術、エネルギーを利用した組織剥離術、縫合装置の開発により、良性・悪性両方の症例において治療能力が向上しています。内視鏡的粘膜下層剥離術(ESD)や内視鏡的粘膜切除術(EMR)は、外科的な完全切除を必要としない早期病変の切除術として普及しつつあります。人工知能(AI)もまた、ポリープの検出、分類、ワークフローの最適化を支援するために大腸内視鏡検査システムに統合されつつあります。

市場拡大に貢献しているエンドユーザーと地域は?

病院と専門手術センターは大腸肛門手術の主要なエンドユーザーであり、患者の処理能力が高く、低侵襲手術やロボット支援手術のための高度なインフラを備えています。外来手術センター(ASC)もまた、特に高所得国において、そのコスト効率と外来ベースで診断や軽度の治療処置を管理する能力により、重要な貢献者として台頭してきています。消化器医療の分散化が進む動向は、都市部と準都市部の両方でASCの拡大を支えています。

地域別では、北米が市場をリードしています。これは、検診プログラムの普及、大腸がんに対する意識の高さ、ロボット支援手術の大幅な導入が背景にある。欧州は、医療インフラが充実しており、内視鏡検査サービスへの投資が拡大していることから、これに続いている。アジア太平洋は、大腸疾患の負担の増加、ヘルスケアアクセスの拡大、欧米型食生活と座りがちなライフスタイルの定着により、急成長地域として浮上しています。中国、インド、日本のような国々は、政府のイニシアチブと民間ヘルスケアの拡大の両方に支えられて、処置件数の急速な伸びを目の当たりにしています。

大腸手術市場の成長の原動力は?

大腸手術市場の成長は、大腸疾患の世界の罹患率の上昇、早期スクリーニングプログラムに対する意識の高まりと実施、手技の安全性と効率性を向上させる技術の進歩など、複数の集約的な力によってもたらされています。人口動態の高齢化や食生活の乱れと関連することが多い大腸がん患者の増加は、ヘルスケアシステムに診断用大腸内視鏡や外科的介入へのアクセス拡大を促しています。同時に、MISやロボット支援技術の向上により、より複雑な手術が可能となり、患者の転帰が改善され、合併症発生率が低下しています。

患者中心のケアモデル、進化する償還の枠組み、価値に基づくヘルスケアの台頭は、病院や医療提供者に在院日数を短縮し、手技の成功率を高める技術の採用を促しています。さらに、官民パートナーシップ、医療ツーリズム、認定手術センターの普及により、発展途上地域における質の高い大腸肛門治療へのアクセスが増加しています。AIを活用した診断と低侵襲技術が引き続き手技ワークフローを再構築していることから、世界の大腸手術市場は診断と治療の両セグメントで力強い勢いを維持すると予想されます。

セグメント

手術タイプ(右半結腸切除術、左半結腸切除術、半結腸亜全切除術、低位前方切除術、腹膜会陰切除術)、適応症(大腸ポリープ適応症、クローン病適応症、大腸がん適応症、大腸炎適応症、過敏性腸症候群適応症)、エンドユーザー(病院&クリニックエンドユーザー、外来手術センターエンドユーザー)

調査対象企業の例(注目の43社)

  • Amgen Inc.
  • Applied Medical Resources Corp
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Coloplast Group
  • Colospan Ltd
  • Cook Medical
  • Conmed Corporation
  • CMR Surgical Ltd
  • Ethicon(Johnson & Johnson)
  • Fujifilm Holdings Corporation
  • Guardant Health
  • Hologic, Inc.
  • Intuitive Surgical, Inc.
  • Karl Storz SE & Co. KG
  • LeMaitre Vascular
  • Medtronic plc
  • Olympus Corporation
  • Stryker Corporation

AI統合

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入(完成品とOEM)に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価(COGS)の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP36558

Global Colorectal Procedure Market to Reach US$34.7 Billion by 2030

The global market for Colorectal Procedure estimated at US$17.5 Billion in the year 2024, is expected to reach US$34.7 Billion by 2030, growing at a CAGR of 12.1% over the analysis period 2024-2030. Right Hemicolectomy Surgery, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$10.6 Billion by the end of the analysis period. Growth in the Left Hemicolectomy Surgery segment is estimated at 14.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.8 Billion While China is Forecast to Grow at 15.9% CAGR

The Colorectal Procedure market in the U.S. is estimated at US$4.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.1 Billion by the year 2030 trailing a CAGR of 15.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.0% and 10.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Colorectal Procedure Market - Key Trends & Drivers Summarized

Why Are Colorectal Procedures Gaining Clinical and Strategic Significance Worldwide?

Colorectal procedures are increasingly central to global healthcare systems due to the rising prevalence of colorectal diseases, including colorectal cancer, inflammatory bowel disease (IBD), diverticulitis, and benign polyps. These procedures encompass a wide range of diagnostic, therapeutic, and surgical interventions, such as colonoscopy, polypectomy, colectomy, anastomosis, and minimally invasive laparoscopic or robotic-assisted surgeries. The aging global population, combined with sedentary lifestyles, dietary changes, and growing incidences of gastrointestinal disorders, is driving the demand for timely colorectal interventions.

Moreover, the shift toward early diagnosis and preventive screening, especially for colorectal cancer, has led to a significant rise in procedural volume. Many countries have implemented national screening programs, which are expanding access to diagnostic colonoscopy and related therapeutic procedures. Advancements in imaging, biopsy techniques, and surgical tools have enhanced procedural accuracy and patient outcomes, positioning colorectal procedures as a high-priority category within gastrointestinal care and oncology services.

How Are Technological Advancements Transforming Colorectal Procedure Outcomes?

The colorectal procedure market is witnessing a technological transformation, particularly in the realm of minimally invasive surgery (MIS). Innovations in laparoscopic instruments, robotic-assisted systems, and high-definition endoscopy have reduced the invasiveness of surgical interventions, resulting in shorter hospital stays, reduced post-operative pain, and faster recovery times. Robotic platforms, in particular, are gaining ground in complex colorectal resections and pelvic surgeries, offering enhanced dexterity, visualization, and precision.

Simultaneously, developments in colorectal stenting, energy-based tissue dissection, and suturing devices have improved therapeutic capabilities in both benign and malignant cases. Endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) are becoming more prevalent for the removal of early-stage lesions without the need for full surgical resection. Artificial intelligence (AI) is also being integrated into colonoscopy systems to assist with polyp detection, classification, and workflow optimization-thereby enhancing diagnostic yield and reducing variability in clinician performance.

Which End-Users and Geographies Are Contributing to Market Expansion?

Hospitals and specialized surgical centers are the primary end-users of colorectal procedures, accounting for high patient throughput and advanced infrastructure for minimally invasive and robotic-assisted interventions. Ambulatory surgical centers (ASCs) are also emerging as significant contributors, especially in high-income countries, due to their cost-efficiency and ability to manage diagnostic and minor therapeutic procedures on an outpatient basis. The trend toward decentralizing gastrointestinal care is supporting the expansion of ASCs in both urban and semi-urban regions.

Regionally, North America leads the market, driven by widespread screening programs, high colorectal cancer awareness, and significant adoption of robotic-assisted surgery. Europe follows closely, with strong healthcare infrastructure and growing investments in endoscopy services. Asia-Pacific is emerging as the fastest-growing region due to increasing colorectal disease burden, expanding healthcare access, and rising adoption of Western diets and sedentary lifestyles. Countries like China, India, and Japan are witnessing rapid procedural volume growth, supported by both government initiatives and private healthcare expansion.

What Is Driving the Growth of the Colorectal Procedure Market?

The growth in the colorectal procedure market is driven by multiple converging forces: rising global incidence of colorectal disorders, growing awareness and implementation of early screening programs, and technological advancements that improve procedural safety and efficiency. The increase in colorectal cancer cases-often associated with aging demographics and poor dietary habits-is prompting healthcare systems to expand access to diagnostic colonoscopies and surgical interventions. Simultaneously, improvements in MIS and robotic-assisted technologies are enabling more complex procedures with better patient outcomes and lower complication rates.

Patient-centric care models, evolving reimbursement frameworks, and the rise of value-based healthcare are pushing hospitals and providers to adopt techniques that reduce length of stay and enhance procedural success. Additionally, public-private partnerships, medical tourism, and the proliferation of accredited surgical centers are increasing access to high-quality colorectal care in developing regions. As AI-enhanced diagnostics and minimally invasive techniques continue to reshape procedural workflows, the global colorectal procedure market is expected to sustain strong momentum across both diagnostic and therapeutic segments.

SCOPE OF STUDY:

The report analyzes the Colorectal Procedure market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Surgery Type (Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery, Abdomino-Perineal Resection Surgery); Indication (Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication, Colitis Indication, Irritable Bowel Syndrome Indication); End-Use (Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Amgen Inc.
  • Applied Medical Resources Corp
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Coloplast Group
  • Colospan Ltd
  • Cook Medical
  • Conmed Corporation
  • CMR Surgical Ltd
  • Ethicon (Johnson & Johnson)
  • Fujifilm Holdings Corporation
  • Guardant Health
  • Hologic, Inc.
  • Intuitive Surgical, Inc.
  • Karl Storz SE & Co. KG
  • LeMaitre Vascular
  • Medtronic plc
  • Olympus Corporation
  • Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Colorectal Procedure - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Colorectal Cancer Throws the Spotlight on Early Diagnostic and Surgical Interventions
    • Aging Population and Increasing Prevalence of Gastrointestinal Disorders Spur Demand for Colorectal Procedures
    • Expansion of National Cancer Screening Programs Strengthens Market for Preventive and Minimally Invasive Colorectal Surgeries
    • Technological Advancements in Endoscopy and Robotic-Assisted Surgery Drive Adoption of Precision-Based Colorectal Procedures
    • Growing Patient Awareness and Access to Gastrointestinal Health Services Propel Procedure Volumes in Emerging Markets
    • Shift Toward Minimally Invasive and Laparoscopic Techniques Enhances Recovery Times and Supports Outpatient Procedures
    • Surge in Colorectal Polyps and Inflammatory Bowel Diseases Accelerates Demand for Therapeutic and Surveillance Procedures
    • Development of Enhanced Imaging Technologies and AI-Based Polyp Detection Tools Supports Clinical Accuracy and Outcomes
    • Integration of Surgical Navigation Systems Improves Efficiency and Reduces Risk in Complex Colorectal Interventions
    • Expansion of Colorectal Procedures in Ambulatory Surgical Centers Reduces Hospital Burden and Costs
    • Rising Adoption of ERAS (Enhanced Recovery After Surgery) Protocols Drives Demand for Less Invasive Procedural Options
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Colorectal Procedure Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Colorectal Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Colorectal Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Colorectal Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Right Hemicolectomy Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Right Hemicolectomy Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Right Hemicolectomy Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Left Hemicolectomy Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Left Hemicolectomy Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Left Hemicolectomy Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Subtotal Hemicolectomy Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Subtotal Hemicolectomy Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Subtotal Hemicolectomy Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Low Anterior Resection Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Low Anterior Resection Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Low Anterior Resection Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Abdomino-Perineal Resection Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Abdomino-Perineal Resection Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Abdomino-Perineal Resection Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Irritable Bowel Syndrome Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Irritable Bowel Syndrome Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Irritable Bowel Syndrome Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Colon Polyps Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Colon Polyps Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Colon Polyps Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Crohn's Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Crohn's Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Crohn's Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Colorectal Cancer Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Colorectal Cancer Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Colorectal Cancer Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Colitis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Colitis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Colitis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospital & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospital & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Hospital & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Colorectal Procedure Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Colorectal Procedure Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Colorectal Procedure Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: China 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: China 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: China 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Colorectal Procedure Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Colorectal Procedure by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Colorectal Procedure by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Colorectal Procedure by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Colorectal Procedure Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: France 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: France 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: France 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Colorectal Procedure Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Colorectal Procedure Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Spain 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Russia 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Colorectal Procedure Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Colorectal Procedure by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Colorectal Procedure by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Colorectal Procedure by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Colorectal Procedure Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Australia 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Colorectal Procedure Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: India 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: India 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: India 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: South Korea 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Colorectal Procedure Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Colorectal Procedure by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Colorectal Procedure by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Colorectal Procedure by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Latin America 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Argentina 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: Brazil 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: Mexico 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Colorectal Procedure Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Colorectal Procedure by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Colorectal Procedure by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Colorectal Procedure by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Middle East 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Iran 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Israel 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: UAE 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Colorectal Procedure Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Colorectal Procedure by Surgery Type - Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Colorectal Procedure by Surgery Type - Percentage Breakdown of Value Sales for Right Hemicolectomy Surgery, Left Hemicolectomy Surgery, Subtotal Hemicolectomy Surgery, Low Anterior Resection Surgery and Abdomino-Perineal Resection Surgery for the Years 2014, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Colorectal Procedure by Indication - Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Colorectal Procedure by Indication - Percentage Breakdown of Value Sales for Irritable Bowel Syndrome Indication, Colon Polyps Indication, Crohn's Disease Indication, Colorectal Cancer Indication and Colitis Indication for the Years 2014, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Colorectal Procedure by End-Use - Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 313: Africa 16-Year Perspective for Colorectal Procedure by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION